Cms Icd-10-Pcs
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alternative Treatment Method for Cervical Ectopic Pregnancy Servikal Ektopik Gebelik İçin Alternatif Tedavi Yöntemi
J Kartal TR 2016;27(2):147-149 CASE REPORT doi: 10.5505/jkartaltr.2015.065982 OLGU SUNUMU Alternative Treatment Method for Cervical Ectopic Pregnancy Servikal Ektopik Gebelik İçin Alternatif Tedavi Yöntemi Ali Emre TAHAOĞLU, Mehmet İrfan KÜLAHÇIOĞLU, Ahmet ESER, Cihan TOĞRU Diyarbakır Obstetrics and Child Health Hospital, Diyarbakır, Turkey Summary Özet Cervical ectopic pregnancy is a very rare form of ectopic Servikal ektopik gebelik, tüm ektopik gebelikler arasında çok pregnancy. Cervical ectopic pregnancy can be a cause of se- nadir rastalanan bir ektopik gebelik formudur. Servikal ektopik vere bleeding and it is associated with high morbidity and gebelik ciddi bir hemoraji nedeni olabilir. Ayrıca yüksek morbi- mortality. In recent years, many conservative methods of dite ve mortalite ile ilişkilidir. Son yıllarda fertiliteyi korumak treatment seeking to preserve fertility have been reported. amacı ile farklı birçok konservatif yaklaşım rapor edilmiştir. Presently described is case of pregnant woman at gesta- Kliniğimize yedi hafta dört gün ile uyumlu fetal kardiyak ak- tional age of 7 weeks and 4 days who was admitted to clinic tivitesi olmayan gebe vajinal kanama şikayeti ile başvurdu. with vaginal bleeding. Fetal cardiac activity was negative. Hasta yüksek servikal sütür ve Mcdonald serklaj uygulanarak Patient was successfully treated with high ligation suture başarı ile tedavi edildi. Servikal gebelik tedavisi hala tartışma and McDonald cerclage. There is no consensus yet on best konusudur. Fakat tedavi konusunda henüz kesin bir fikir birliği treatment of cervical ectopic pregnancy, but conservative bulunmamaktadır. Konservatif yaklaşım hastayı histerektomi methods can avoid major surgical procedure such as hyster- gibi büyük bir cerrahiden ve bunun getirdiği kötü sonuçlardan ectomy and its consequences. -
Core Neurosurgery
BAYLOR SCOTT & WHITE TEXAS SPINE & JOINT HOSPITAL NEUROLOGICAL SURGERY CLINICAL PRIVILEGES NAME: ________________________________ Initial appointment Reappointment All new applicants must meet the following requirements as approved by the governing body. To be eligible to apply for core privileges in neurological surgery, the initial applicant must meet the following criteria: Successful completion of ACGME or American Osteopathic Association accredited residency in neurological surgery. Required previous experience: Applicants for initial appointment must be able to demonstrate the performance of at least 50 neurological surgical procedures, reflective of the scope of privileges requested, during the last 12 months or demonstrate successful completion of residency or fellowship within the past 12 months. Reappointment requirements: To be eligible to renew core privileges in Neurological Surgery, the applicant must meet the following maintenance of privilege criteria: Current demonstrated competence and an adequate volume of neurological surgery procedures with acceptable results, reflective of the scope of privileges requested, for the past 24 months based on results of ongoing professional practice evaluation and outcomes. Evidence of current ability to perform privileges requested is required of all applicants for renewal of privileges NEUROLOGICAL SURGERY CORE PRIVILEGES Requested: Admit, evaluate, diagnose, consult and provide nonoperative and pre-, intran, and postoperative care to patients of all ages presenting with injuries -
Neurosurgery
KALEIDA HEALTH Name ____________________________________ Date _____________ DELINEATION OF PRIVILEGES - NEUROSURGERY All members of the Department of Neurosurgery at Kaleida Health must have the following credentials: 1. Successful completion of an ACGME accredited Residency, Royal College of Physicians and Surgeons of Canada, or an ACGME equivalent Neurosurgery Residency Program. 2. Members of the clinical service of Neurosurgery must, within five (5) years of appointment to staff, achieve board certification in Neurosurgery. *Maintenance of board certification is mandatory for all providers who have achieved this status* Level 1 (core) privileges are those able to be performed after successful completion of an accredited Neurosurgery Residency program. The removal or restriction of these privileges would require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. PLEASE NOTE: Please check the box for each privilege requested. Do not use an arrow or line to make selections. We will return applications that ignore this directive. LEVEL I (CORE) PRIVILEGES Basic Procedures including: Admission and Follow-Up Repair cranial or dural defect or lesion History and Physical for diagnosis and treatment plan* Seizure Chest tube placement Sterotactic framed localization of lesion Debride wound Sterotactic frameless localization Endotracheal intubation Transsphenoidal surgery of pituitary lesion Excision of foreign body Trauma Insertion of percutaneous arterial -
16 Non-Delivery Obstetric Procedures
16 Non-delivery Obstetric Procedures Cervical Cerclage ...................... 357 AnestheticOptions.................... 358 Regional Anesthesia .................. 358 General Anesthesia .................. 359 CerclageRemoval.................... 359 Dilation and Evacuation (D&E) .............. 360 AnestheticOptions.................... 360 Postpartum Tubal Ligation ................. 362 TimingofTubalLigation................. 362 Physiologic Changes of Pregnancy in the Postpartum Period ..............363 AnestheticTechniques.................. 363 Epidural Anesthesia .................. 363 Spinal Anesthesia ................... 364 General Anesthesia .................. 365 PostoperativePainRelief................. 366 Cervical Cerclage Cervical incompetence complicates up to 1% of all pregnan- cies. It is characterized by premature dilation of the internal cervical os and shortening of the cervix from the internal os to the uterine cavity. It is associated with early pregnancy loss and premature birth. Cervical cerclage is a procedure performed at least 23,000 times annually in the United States.1 There are three techniques in use at the present time: McDonald transvaginal approach, Shirodkar transvaginal approach, and the abdominal cerclage. The first two techniques are technically easier and much more popular. All cerclage pro- cedures involve a circumferential suture or band tied around the cervical os to strengthen and support the cervix and prevent further dilation. The McDonald technique is simpler and is sim- ply a purse-string suture placed in the neck of the cervix as high S. Datta et al., Obstetric Anesthesia Handbook, DOI 10.1007/978-0-387-88602-2_16, C Springer Science+Business Media, LLC 2006, 2010 358 Non-delivery Obstetric Procedures in the vagina as possible. The Shirodkar involves dissection of the bladder and rectum away from the anterior and posterior aspects of the cervix to allow a imbedded band to be placed higher on the cervix, closer to the internal os. -
ICD~10~PCS Complete Code Set Procedural Coding System Sample
ICD~10~PCS Complete Code Set Procedural Coding System Sample Table.of.Contents Preface....................................................................................00 Mouth and Throat ............................................................................. 00 Introducton...........................................................................00 Gastrointestinal System .................................................................. 00 Hepatobiliary System and Pancreas ........................................... 00 What is ICD-10-PCS? ........................................................................ 00 Endocrine System ............................................................................. 00 ICD-10-PCS Code Structure ........................................................... 00 Skin and Breast .................................................................................. 00 ICD-10-PCS Design ........................................................................... 00 Subcutaneous Tissue and Fascia ................................................. 00 ICD-10-PCS Additional Characteristics ...................................... 00 Muscles ................................................................................................. 00 ICD-10-PCS Applications ................................................................ 00 Tendons ................................................................................................ 00 Understandng.Root.Operatons..........................................00 -
Neurosurgery
March 10, 2017 St Elizabeth Healthcare 9:02 am Privileges for: Neurosurgery Request ST. ELIZABETH - EDGEWOOD ST. ELIZABETH - FLORENCE ST. ELIZABETH - FT. THOMAS ST. ELIZABETH - GRANT CO. (Surgical & other invasive procedures requiring general anesthetic are not offered) MEC Approval: August 27, 2009; Rev. November 15, 2012, February 27, 2014 Board Approval: September 14, 2009; Rev. January 7, 2013, May 5, 2014 DEPARTMENT APPROVAL ________Approved ________Disapproved ___________________________________________ ________________ Department/Section Chair Signature Date MINIMUM REQUIREMENTS Degree required: MD or DO Successful completion of an ACGME or AOA accredited residency in neurosurgery. Note: For Practitoners (excluding AHPs) who apply for membership after March 2, 2009 be and remain (with a lapse of no longer than one year) board certified in their principal practice specialty, or become and remain (with a lapse of no longer than one year) board certified within six years of completion of their post-graduate medical training. Only those boards recognized by the American Board of Medical Specialties or the American Osteopathic Association are acceptable. This board certification requirement does not apply to applicants who on March 2, 2009 were members in good standing on the medical staff of the St. Luke Hospitals or St. Elizabeth Medical Center. PRIVILEGES REQUESTED Pursuant to Bylaws Section 6.1.4, practitioners may exercise the privileges requested and awarded below only at facilities where St. Elizabeth Healthcare offers those services. I. Core Privileges: Core privileges in neurosurgery include the care, treatment or services listed immediately below. I specifically acknowledge that board certification alone does not necessarily qualify me to perform all core privileges or assure competence in all clinical areas. -
Term Pregnancy in a Bicornuate Uterus: Complications, Diagnostic and Therapeutic Challenges in a Low Resource Setting (Douala, Cameroon)
International Journal of Medical and Pharmaceutical Case Reports 11(3): 1-4, 2018; Article no.IJMPCR.43964 ISSN: 2394-109X, NLM ID: 101648033 Term Pregnancy in a Bicornuate Uterus: Complications, Diagnostic and Therapeutic Challenges in a Low Resource Setting (Douala, Cameroon) 1,2 1,2 1 3 4* A. A. Tazinya , V. F. Feteh , R. C. Ngu , N. N. Bechem and G. E. Halle-Ekane 1Mboppi Baptist Hospital Douala, Douala, Cameroon. 2Medical Doctors Research Group Douala, Douala, Cameroon. 3Department of Public Health and Epidemiology, Nottingham University, England. 4Department of Obstetrics/ Gynecology, Faculty of Health Sciences, University of Buea, Cameroon. Authors’ contributions This work was carried out in collaboration between all authors. Authors AAT, VFF, NNB and RCN were involved in the management of the patient. Authors AAT and GEHE wrote the first draft of the manuscript. Authors AAT, VFF and NNB managed the literature searches. All authors read and approved the final manuscript. Article Information DOI: 10.9734/IJMPCR/2018/43964 Editor(s): (1) Dr. Erich Cosmi, Director of Maternal and Fetal Medicine Unit, Department of Woman and Child Health, University of Padua School of Medicine, Padua, Italy. Reviewers: (1) Donnette Simms-Stewart, University of the West Indies, Jamaica. (2) Ikobho Ebenezer Howells, Niger Delta University Teaching Hospital, Nigeria. (3) Elisabete Gonçalves, Centro Hospitalar Universitário do Algarve, Portugal. Complete Peer review History: http://www.sciencedomain.org/review-history/26173 Received 16th June 2018 Accepted 5th September 2018 Case Report th Published 10 September 2018 ABSTRACT Severe uterine malformations are usually associated with infertility. Furthermore, a term pregnancy in the case of a severe uterine malformation is rare because spontaneous abortions and uterine ruptures are not uncommon before the third trimester. -
Cervical Stitch
Information for you Published in May 2018 Cervical stitch About this information This information is for you if you want to know about having a cervical stitch, which is also called cervical cerclage. You may also find it helpful if you are a partner, relative or friend of someone who is in this situation. A glossary of all medical terms used is available on the RCOG website at: www.rcog.org.uk/en/patients/ medical-terms. Key points • A cervical stitch may help to keep your cervix closed and may reduce the risk of you giving birth early. • You may be offered a cervical stitch if you are at risk of giving birth early. • A cervical stitch is usually put in between 12 and 24 weeks of pregnancy and then removed at 36–37 weeks unless you go into labour before this. What is a cervical stitch? A cervical stitch is an operation where a stitch is placed around the cervix (neck of the womb). It is usually done between 12 and 24 weeks of pregnancy although occasionally it may be done at later stages in pregnancy. Transabdominal A cervical stitch is more commonly put in Transvaginal vaginally (transvaginal) and less commonly by an abdominal route (transabdominal) 1 Why is it done? Babies born early (before 37 completed weeks of pregnancy) have an increased risk of short- and long-term health problems. You can find out more about this from the NICE guidance on Preterm Labour and Birth, which can be found at: www.nice.org.uk/guidance/ng25/ifp/chapter/About-this-information. -
Cervical Cancer
Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States 2010 Jemal, A. et al. CA Cancer J Clin 2010; 60:277-300 1 Estimated gynecologic cancer deaths United States 2010 Jemal, A. et al. CA Cancer J Clin 2010; 60:277-300 Decreasing Trends of Cervical Cancer Incidence in the U.S. • With the advent of the Pap smear, the incidence of cervical cancer has dramatically declined. • The curve has been stable for the past decade because we are not reaching the unscreened population. Reprinted by permission of the American Cancer Society, Inc. 2 Cancer incidence worldwide GLOBOCAN 2008 Cervical Cancer New cases Deaths United States 12,200 4,210 Developing nations 530,000 275,000 • 85% of cases occur in developing nations ¹Jemal, CA Cancer J Clin 2010 GLOBOCAN 2008 3 Cervical Cancer • Histology – Squamous cell carcinoma (80%) – Adenocarcinoma (15%) – Adenosquamous carcinoma (3 to 5%) – Neuroendocrine or small cell carcinoma (rare) Human Papillomavirus (HPV) • Etiologic agent of cervical cancer • HPV DNA sequences detected is more than 99% of invasive cervical carcinomas • High risk types: 16, 18, 45, and 56 • Intermediate types: 31, 33, 35, 39, 51, 52, 55, 58, 59, 66, 68 HPV 16 accounts for ~80% of cases HPV 18 accounts for 25% of cases Walboomers JM, Jacobs MV, Manos MM, et al. J Pathol 1999;189(1):12-9. 4 Viral persistence and Precancerous progression Normal lesion cervix Regression/ clearance Invasive cancer Risk factors • Early age of sexual activity • Cigggarette smoking • Infection by other microbial agents • Immunosuppression – Transplant medications – HIV infection • Oral contraceptive use • Dietary factors – Deficiencies in vitamin A and beta carotene 5 Multi-Stage Cervical Carcinogenesis Rosenthal AN, Ryan A, Al-Jehani RM, et al. -
Chapter 9 Management of Cervical Cancer Complicating Pregnancy
Page 91 Chapter 9 Management of Cervical Cancer Complicating Pregnancy Overview In recent years, cervical cancer is being seen increasingly often in younger women. More cervical cancer is detected during pregnancy due to women becoming pregnant later in their lives, in turn the result of later marriage. The basic treatment strategy is the same as for non-pregnant women. However, the treating institution must provide individualized management depending on clinical stage, weeks of gestation, and the patient’s desire to continue the pregnancy. If the cancer is at an early stage, concurrent cervical cancer treatment and continuation of pregnancy is possible in many cases. For advanced cancer, the management will differ depending on whether or not the fetus is at a stage in which it is viable outside the uterus. If the fetus is sufficiently developed, treatment for cervical cancer is promptly performed as soon as the mother delivers the fetus. If the fetus has not reached such a stage, the maternal life should be given priority, and the cancer treated. In recent years, neonatal medicine has rapidly advanced, and social values have become diversified. Accordingly, even if a cancer is found at a stage when the fetus is not viable outside the uterus, some patients and their families have a strong desire to wait to begin treatment until it is viable. There is no consensus on the allowable waiting period, and at present treatment should only be delayed with caution. Page 92 CQ33 How should cervical cancer complicating pregnancy be managed? Recommendations (1) Cone biopsy may be delayed until after delivery as long as a microinvasive or more advanced lesion is not suspected on the results of cytology, colposcopy, or biopsy (Grade C). -
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
BMJ Open: first published as 10.1136/bmjopen-2020-044493 on 19 January 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 24, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-044493 on 19 January 2021. Downloaded from Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: A Population-based Cohort Study ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-044493 Article Type: Protocol Date Submitted by the 04-Sep-2020 Author: Complete List of Authors: -
Icd-9-Cm (2010)
ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular